Psyence Biomedical Ltd. Common Shares (PBM) Stock Analysis

Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded company in the HEALTHCARE sector. It trades at $2.97, carries a market capitalization of $11.18M. This page summarizes the public market data, fundamentals, and frequently asked questions for PBM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Price: $2.97
Market Cap: $11.18M
EPS: $-12.62
52-Week High: $74.94
52-Week Low: $1.92

Market Sentiment

Psyence Biomedical Ltd. Common Shares currently has a Neutral sentiment score of -0.09.

About Psyence Biomedical Ltd. Common Shares

None

GNG Research Analysis

GNG Research scores Psyence Biomedical Ltd. Common Shares (PBM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PBM.

Frequently Asked Questions

Does PBM pay dividends?

Psyence Biomedical Ltd. Common Shares (PBM) does not currently pay a regular dividend.

What is PBM's market cap?

Psyence Biomedical Ltd. Common Shares (PBM) has a market capitalization of $11.18M with a current stock price of $2.97.